Stay updated on Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Sign up to get notified when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.

Latest updates to the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new site revision label Revision: v3.4.2 was added, and older revision notices (Revision: v3.4.1) along with a government-funding notice were removed. These are administrative changes that do not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check17 days agoChange DetectedAdded a government funding status notice about potential delays and the NIH open status. Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check24 days agoChange DetectedThe page adds a glossary display option and updates QC metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check60 days agoChange DetectedLocations section reorganized to list study sites by state under a single Locations heading (Florida, Massachusetts, New York, Tennessee, Texas, Virginia), replacing the former per-state 'X Locations' subsections. This clarifies where the trial is conducted and makes site information more accessible to potential participants.SummaryDifference0.6%

- Check82 days agoChange DetectedThe page now shows a new revision label 'Revision: v3.3.2' and the previous 'Revision: v3.3.1' label appears to have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedMinor revision update from v3.2.0 to v3.3.1 with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.